Elad Asher: Immature Platelet Fraction Is Linked to Worse Outcomes in ICCU Patients
Elad Asher, Interventional cardiologist, Head of ICCU, Deputy Director of the Heart Center at SZMC, and Associate Professor of Cardiology at the Hebrew University of Jerusalem, shared a post on X about a recent article he and his colleagues co-authored, published in Seminars in Thrombosis and Hemostasis, adding:
”Pleased to share our new paper in Thrombosis and Haemostasis.
In an unselected ICCU cohort, higher immature platelet fraction was independently associated with adverse outcomes, supporting IPF as a readily available risk marker.”
Title: Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit
Authors: Elad Asher, Louay Taha, Mohammad Karmi, Akiva Brin, Pierre Sabouret, Mamas A. Mamas, Noam Fink, Ari Naimark, Amjad Abu-Salman, Michael Glikson
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 15:53Leonard Valentino: Advancing a New Model of Patient-Led Research
-
Sep 14, 2026, 15:48Adishwar Rao: LAAC vs Oral Anticoagulation in Atrial Fibrillation
-
Sep 14, 2026, 15:36Lesley Van Wyk: Hemolytic Anemia Quick Revision – Tips and Tricks
-
Sep 14, 2026, 15:35Maha Othman: ISTH-BAT Reference Ranges Validated Across Five Continents in Children
-
Sep 14, 2026, 15:30Umberto Pensato։ Left Ventricular Dysfunction and DOAC Benefit in ESUS
-
Sep 14, 2026, 15:22Meral Kayikcioglu: Why Do Women and Men Differ in LDL-C Management?
-
Sep 14, 2026, 15:22James Crowley: The Complex Role of CRP in Cardiovascular Risk and Atherosclerosis
-
Sep 14, 2026, 15:16Factor XIII Deficiency An Often-Missed Bleeding Disorder
-
Sep 14, 2026, 15:07Raffaele Piccolo: Heparin Against Jellyfish Venom?